Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsProvidence Medicare Part B Step Therapy Prior Auth…
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy N/A

    Medicare Part B Step Therapy Criteria for Part B Drugs

    Customize your policy alerts

    Sign up for all Providence Health Plan policy alerts

    Know when Providence Health Plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy, prior authorization, and the list of Medicare Part B drugs (by HCPCS/CPT) subject to step therapy protocols for Providence Medicare Advantage Plans; applies to providers prescribing or administering Part B medications for plan members.

    Policy Summary
    PayerProvidence Health Plan
    PolicyMedicare Part B Step Therapy Criteria for Part B Drugs
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateJul 1, 2026
    Last ReviewJul 1, 2026
    Next Review DateJul 1, 2026
    Key ActionSubmit prior authorization with clinical documentation showing trials of required step drugs or reasons they were not used when requesting coverage for Step 2 or Step 3 drugs.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ~200listed procedure/HCPCS codes and medications
    365lookback days
    Step 1–3step levels
    Prior auth requiredauth requirement

    Step Therapy and Coverage Rules

    Step therapy coverage rules

    Covered when ALL of the following criteria are met:

    General step therapy rule: Member must try required earlier step drug(s) before a later-step drug is covered unless a prior use exemption or documented medical reason existsprior trials or exemptions

    Prior use of the non-preferred drug within 365 days waives step requirement

    Step 1 (Preferred) drugs: Step 1 drugs are preferred; they usually require prior authorization. If a Step 1 drug does not require prior authorization, that will be indicated in the drug listprior authorization as indicated
    Step 2 (Non-preferred) drugs: Step 2 drugs always require prior authorization. The prescriber must document one of: (1) why the required Step 1 drug was ineffective or not tolerated, (2) why the Step 2 drug is clinically preferred, or (3) evidence the member received the Step 2 drug within the past 365 daysdocumented clinical rationale or prior use within 365 days
    Step 3 (Non-preferred) drugs: Step 3 drugs always require prior authorization. The prescriber must document one of: (1) why both required Step 1 and Step 2 drugs were ineffective or not tolerated, (2) why the Step 3 drug is clinically preferred, or (3) evidence the member received the required Step 1 and/or Step 2 drug(s) within the past 365 daysdocumented clinical rationale or prior use within 365 days
    Documentation and denial risk: Provider must submit clinical information showing trials of prior step drugs, reasons for failure/intolerance, or evidence of prior use within 365 days when requesting prior authorization for Step 2 or Step 3 drugs. Failure to document required trials or a medically appropriate reason will result in non-coverage/denialclinical documentation

    HCPCS/CPT Codes and Lookback

    Listed HCPCS/CPT codes and medications (partial sample)HCPCS
    J3262Actemra (Tocilizumab)
    J0791Adakveo (Crizanlizumab-tmca)
    J7173Alhemo (Concizumab-mtci)
    J1552Alyglo (Immune globulin, gamma(IGG)-stwk)
    Q5126Alymsys (Bevacizumab-maly)
    J1554Asceniv (Immune globulin)
    Q5161Aukelso/Bosaya (denosumab-kyqq)
    J9035Avastin (Bevacizumab)
    J3145Aveed (Testosterone undecanoate)
    Q5121Avsola (Infliximab-axxq)
    1–10 of 15
    1/2
    Prior use lookback — 365 days
    Lookback period365 days — prior use of the non-preferred drug within the past 365 days waives the step therapy requirement.
    Applies toMembers who have received the non-preferred Part B drug within the past 365 days are exempt from step requirements.
    ScopeUsed to determine exemption from Step 1→2/3 trial requirements for Medicare Part B medications under Providence Medicare Advantage plans.

    Prior Authorization and Documentation Requirements

    Prior Authorization

    Prior authorization required for Step 2 and Step 3 (Step 1 usually)

    Step 2 and Step 3 drugs always require prior authorization; Step 1 drugs usually require prior authorization but some Step 1 drugs may not—see individual drug entries. When requesting prior authorization for a Step 2 or Step 3 drug the provider must submit the information described for that step (clinical rationale, prior trials, or evidence of prior use).

    • Step 1 drugs: usually require prior authorization; exceptions are noted in the drug list.
    • Step 2 drugs: always require prior authorization plus documentation (see Step 2 documentation requirements).
    • Step 3 drugs: always require prior authorization plus documentation (see Step 3 documentation requirements).
    Step Therapy

    Step therapy mechanics — trial of preferred drug first; prior use exemption

    Step therapy requires a documented trial of a preferred (Step 1) drug before a non-preferred (Step 2 or Step 3) drug is covered; prior use of the requested non-preferred drug within the past 365 days exempts the member from step requirements.

    Policy Background

    Medicare Part B covers many medically administered medications, including injectable drugs and biologics used across a range of conditions. This policy applies to Part B medications for Providence Medicare Advantage members and explains how step therapy is used to manage access to those therapies. Step therapy is a utilization management process that encourages use of a preferred agent first (labeled Step 1) before covering non-preferred agents (Step 2 or Step 3), and the list of affected HCPCS/CPT codes and products is provided in the document.

    Under these Part B protocols, Step 1 drugs are the preferred/first-line agents and Step 2 and Step 3 drugs are non-preferred; Step 2 and Step 3 drugs always require prior authorization. Step 1 drugs usually require prior authorization, though the list indicates when a given Step 1 product does not. Prior authorization requests for later-step drugs must include clinical documentation explaining prior trials, intolerance, lack of efficacy, or other medical rationale.

    A prior-use exemption is available when the member has received the requested non-preferred drug within the prior 365 days; in that case the step requirement is waived. The step therapy rules can apply across Part B and Part D agents (for example, a Part B drug may not be covered unless a Part D drug was tried first, or vice versa) depending on the clinical regimen described.

    Step Definitions

    Step 1 — Preferred drug
    DefinitionStep 1 = Preferred drug (usually first-line); may still require prior authorization.
    Prior authorization noteStep 1 drugs usually require prior authorization; if a Step 1 drug does not require prior authorization this is indicated on the individual drug list.
    Role in step therapyMember generally must try a Step 1 drug before receiving Step 2 or Step 3 drugs unless an exemption applies.
    Step 2 / Step 3 — Non-preferred drugs
    DefinitionStep 2 / Step 3 = Non-preferred drugs that require prior authorization and documentation of prior trials or clinical justification.
    Documentation required for Step 2Provider must document why the Step 1 drug didn’t work or can’t be used, why the Step 2 drug is best, or evidence the Step 2 drug was used in the past 365 days.

    Step Level Requirements

    StepDescriptionPrior authorization required
    Step 1Preferred drug — first-line; may still require prior authorization
    StepDescriptionPrior authorization & documentation required
    Step 2Non-preferred drug; coverage requires documentation that Step 1 cannot be used or has failed (trial, intolerance, or clinical rationale)Always required — provider must submit documentation why Step 1 was ineffective or not tolerated, or evidence of prior use within 365 days
    StepDescriptionPrior authorization & documentation required
    Step 3Non-preferred drug; coverage requires documentation that Step 1 and Step 2 cannot be used or have failed (trial, intolerance, or clinical rationale)Always required — provider must submit documentation why Step 1 and Step 2 were ineffective or not tolerated, or evidence of prior use within 365 days
    Policy Summary
    PayerProvidence Health Plan
    PolicyMedicare Part B Step Therapy Criteria for Part B Drugs
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateJul 1, 2026
    Last ReviewJul 1, 2026
    Next Review DateJul 1, 2026
    Key ActionSubmit prior authorization with clinical documentation showing trials of required step drugs or reasons they were not used when requesting coverage for Step 2 or Step 3 drugs.
    SourceLink
    On This Page
    Step Therapy and Coverage RulesHCPCS/CPT Codes and LookbackPrior Authorization and Documentation RequirementsPolicy BackgroundStep DefinitionsStep Level Requirements
    • Before coverage of a Step 3 drug, the member must have tried a Step 1 and a Step 2 drug unless an exemption applies.
    • Prior use exemption: member use of the non-preferred drug within the past 365 days waives the step requirement.
    Documentation Required

    Submit clinical rationale and treatment history with PA requests

    When requesting prior authorization for Step 2 or Step 3 drugs the provider must submit clinical information documenting prior trials of required step drugs, reasons those drugs were ineffective or not tolerated, or evidence the member received the drug(s) within the past 365 days.

    • Document attempts with Step 1 (and Step 2 when applicable) including duration, dose, and clinical outcome.
    • If the prior step drug was not tried, provide a medical reason (e.g., intolerance, contraindication) explaining why it is not appropriate.
    Denial Risk

    Denial risk if step therapy documentation is missing

    Failure to document required trials of prior step drugs or a medically appropriate reason they were not used may result in non-coverage or denial of Step 2 and Step 3 drugs.

    • If documentation does not show prior trials or acceptable medical justification, the authorization request may be denied.
    • Provide evidence of prior use within 365 days when claiming a prior use exemption to avoid step requirements.
    Documentation required for Step 3Provider must document why Step 1 and Step 2 drugs didn’t work or can’t be used, why the Step 3 drug is best, or evidence of prior use of Step 1 and/or Step 2 in the past 365 days.
    Prior authorization requirementStep 2 and Step 3 drugs always require prior authorization; lack of required documentation may result in non-coverage/denial.